Roel Funke
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 2%
- Molecular Biology top 10%
- Cancer Research top 2%
- Co-authors
- Luciana MolineroSylvia AdamsPeter SchmidAmreen HusainVéronique DièrasHiroji IwataSherene LoiCarlos H. Barrios
- Topics
- Cancer Immunotherapy and Biomarkers (21 papers)Lung Cancer Treatments and Mutations (7 papers)Advanced Breast Cancer Therapies (6 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Roel Funke
43 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 3.5k
- Pulmonary and Respiratory Medicine 1.4k
- Immunology 1.3k
- Molecular Biology 1.0k
- Cancer Research 953
Countries citing papers authored by Roel Funke
This map shows the geographic impact of Roel Funke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roel Funke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roel Funke more than expected).
Fields of papers citing papers by Roel Funke
This network shows the impact of papers produced by Roel Funke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roel Funke. The network helps show where Roel Funke may publish in the future.
Co-authorship network of co-authors of Roel Funke
This figure shows the co-authorship network connecting the top 25 collaborators of Roel Funke. A scholar is included among the top collaborators of Roel Funke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roel Funke. Roel Funke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 114 | |
| 2 | 9 | |
| 3 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancerbreakdown → | 3005 |
| 4 | 38 | |
| 5 | 24 | |
| 6 | 61 | |
| 7 | 34 | |
| 8 | 86 | |
| 9 | 33 | |
| 10 | 3 | |
| 11 | 45 | |
| 12 | 94 | |
| 13 | 63 | |
| 14 | 17 | |
| 15 | Yeast and bacterial artificial chromosome (YAC and BAC) clones of the model legume Lotus japonicus | 3 |
| 16 | 8 | |
| 17 | 5 | |
| 18 | 5 | |
| 19 | 16 | |
| 20 | 318 |
About Roel Funke
Roel Funke is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 43 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Oncology (3.5k citations), Cancer Research (953 citations) and Immunology (1.3k citations). Roel Funke has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Luciana Molinero, Sylvia Adams, Peter Schmid, Amreen Husain, Véronique Dièras, Hiroji Iwata, Sherene Loi, Carlos H. Barrios, Gail S. Wright and Volkmar Henschel. Their work appears in journals such as Nature, New England Journal of Medicine and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.